Literature DB >> 31645646

GGA3-mediated recycling of the RET receptor tyrosine kinase contributes to cell migration and invasion.

Mathieu J F Crupi1, Sarah M Maritan1, Eduardo Reyes-Alvarez1, Eric Y Lian1, Brandy D Hyndman1, Aisha N Rekab1, Serisha Moodley1, Costin N Antonescu2, Lois M Mulligan3.   

Abstract

The RET receptor tyrosine kinase plays important roles in regulating cellular proliferation, migration, and survival in the normal development of neural crest derived tissues. However, aberrant activation of RET, through oncogenic mutations or overexpression, can contribute to tumourigenesis, regional invasion, and metastasis of several human cancers. RET is expressed as two main isoforms with unique C-terminal sequences that differ in protein interactions and subcellular trafficking in response to RET activation, and which also have distinct oncogenic potentials. The long isoform, termed RET51, is internalized from the membrane in response to stimulation by its ligand, GDNF, but is known to recycle back to the surface via RAB11 endosomes. However, the mechanisms regulating this process and its cellular effects have not been defined. Here, we show that recycling of RET51 requires a multicomponent complex that includes the endosomal-sorting protein GGA3, which mediates GDNF-dependent slow recycling of RET51 receptors to the plasma membrane. Our data show that the GRB2 adapter associates with RET51 through interactions with its C-terminal sequences, facilitating recruitment of active ARF6 and GGA3 interaction, and that depletion of GGA3 or ARF6 reduced RET51 recycling. Further, GGA3 knockdown accelerated RET51 degradation and also attenuated RET-mediated AKT activation. Finally, we showed that recycling of RET51 to the cell surface through association with GGA3 and ARF6 contributes to RET51-dependent cell motility, migration, and invasion. Our data establish RET recycling as a mechanism coordinating location and duration of RET signals in order to direct cell movement and invasion.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31645646     DOI: 10.1038/s41388-019-1068-z

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  46 in total

1.  Characterization of ret proto-oncogene mRNAs encoding two isoforms of the protein product in a human neuroblastoma cell line.

Authors:  T Tahira; Y Ishizaka; F Itoh; T Sugimura; M Nagao
Journal:  Oncogene       Date:  1990-01       Impact factor: 9.867

Review 2.  Rab proteins and the compartmentalization of the endosomal system.

Authors:  Angela Wandinger-Ness; Marino Zerial
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-10-23       Impact factor: 10.005

Review 3.  Endocytosis of receptor tyrosine kinases.

Authors:  Lai Kuan Goh; Alexander Sorkin
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-05-01       Impact factor: 10.005

Review 4.  RET revisited: expanding the oncogenic portfolio.

Authors:  Lois M Mulligan
Journal:  Nat Rev Cancer       Date:  2014-03       Impact factor: 60.716

5.  Differential roles of RET isoforms in medullary and papillary thyroid carcinomas.

Authors:  Eric Y Lian; Sarah M Maritan; Jessica G Cockburn; Katayoon Kasaian; Mathieu J F Crupi; David Hurlbut; Steven J M Jones; Sam M Wiseman; Lois M Mulligan
Journal:  Endocr Relat Cancer       Date:  2016-11-21       Impact factor: 5.678

Review 6.  ESCRT-dependent cargo sorting at multivesicular endosomes.

Authors:  E B Frankel; Anjon Audhya
Journal:  Semin Cell Dev Biol       Date:  2017-08-08       Impact factor: 7.727

7.  The long and short isoforms of Ret function as independent signaling complexes.

Authors:  Brian A Tsui-Pierchala; Rebecca C Ahrens; Robert J Crowder; Jeffrey Milbrandt; Eugene M Johnson
Journal:  J Biol Chem       Date:  2002-06-28       Impact factor: 5.157

8.  Distinct Temporal Regulation of RET Isoform Internalization: Roles of Clathrin and AP2.

Authors:  Mathieu J F Crupi; Piriya Yoganathan; Leslie N Bone; Eric Lian; Andrew Fetz; Costin N Antonescu; Lois M Mulligan
Journal:  Traffic       Date:  2015-09-21       Impact factor: 6.215

Review 9.  Reciprocal regulation of signaling and endocytosis: Implications for the evolving cancer cell.

Authors:  Sandra L Schmid
Journal:  J Cell Biol       Date:  2017-07-03       Impact factor: 10.539

Review 10.  GDNF and the RET Receptor in Cancer: New Insights and Therapeutic Potential.

Authors:  Lois M Mulligan
Journal:  Front Physiol       Date:  2019-01-07       Impact factor: 4.566

View more
  5 in total

1.  RET isoforms contribute differentially to invasive processes in pancreatic ductal adenocarcinoma.

Authors:  Eric Y Lian; Brandy D Hyndman; Serisha Moodley; Sarah M Maritan; Lois M Mulligan
Journal:  Oncogene       Date:  2020-09-03       Impact factor: 9.867

2.  Evaluating Cell Membrane Localization and Intracellular Transport of Proteins by Biotinylation.

Authors:  Eduardo Reyes-Alvarez; Timothy J Walker; Lois M Mulligan
Journal:  Methods Mol Biol       Date:  2022

3.  Endocytic trafficking of GAS6-AXL complexes is associated with sustained AKT activation.

Authors:  Agata Poświata; Kamila Kozik; Marta Miączyńska; Daria Zdżalik-Bielecka
Journal:  Cell Mol Life Sci       Date:  2022-05-27       Impact factor: 9.207

4.  Reciprocal priming between receptor tyrosine kinases at recycling endosomes orchestrates cellular signalling outputs.

Authors:  Michael P Smith; Harriet R Ferguson; Jennifer Ferguson; Egor Zindy; Katarzyna M Kowalczyk; Thomas Kedward; Christian Bates; Joseph Parsons; Joanne Watson; Sarah Chandler; Paul Fullwood; Stacey Warwood; David Knight; Robert B Clarke; Chiara Francavilla
Journal:  EMBO J       Date:  2021-06-04       Impact factor: 14.012

Review 5.  Chasing the Target: New Phenomena of Resistance to Novel Selective RET Inhibitors in Lung Cancer. Updated Evidence and Future Perspectives.

Authors:  Sara Fancelli; Enrico Caliman; Francesca Mazzoni; Marco Brugia; Francesca Castiglione; Luca Voltolini; Serena Pillozzi; Lorenzo Antonuzzo
Journal:  Cancers (Basel)       Date:  2021-03-04       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.